T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
GCM Grosvenor
GCMG
$2.82B
| $208K | ﹤0.01% |
16,951
+3,082
| +22% | +$36.6K |
|
2652
Sanara MedTech
SMTI
$315M
| $208K | ﹤0.01% |
+6,237
| New | +$212K |
|
2653
TAL Education Group
TAL
$6.36B
| $208K | ﹤0.01% |
20,684
-1,919
| -8% | -$20.2K |
|
2654
Titan Machinery
TITN
$421M
| $208K | ﹤0.01% |
14,655
+1,197
| +9% | +$17.3K |
|
2655
Dianthus Therapeutics
DNTH
$6.18B
| $207K | ﹤0.01% |
9,468
+1,647
| +21% | +$42.4K |
|
2656
Commercial Vehicle Group
CVGI
$129M
| $206K | ﹤0.01% |
82,711
+9,800
| +13% | +$26.2K |
|
|
FPI
2657
Farmland Partners
FPI
$426M
| $206K | ﹤0.01% |
17,460
+3,322
| +23% | +$39K |
|
|
FSP
2658
Franklin Street Properties
FSP
$46.5M
| $205K | ﹤0.01% |
111,568
+7,311
| +7% | +$13.4K |
|
2659
KRONOS Worldwide
KRO
$988M
| $205K | ﹤0.01% |
21,007
+930
| +5% | +$10.4K |
|
2660
PACS Group
PACS
$7.26B
| $204K | ﹤0.01% |
15,524
+2,598
| +20% | +$66.7K |
|
|
ENFN
2661
DELISTED
Enfusion, Inc.
ENFN
| $204K | ﹤0.01% |
19,746
+3,238
| +20% | +$31.3K |
|
2662
Altimmune
ALT
$560M
| $203K | ﹤0.01% |
28,146
+4,158
| +17% | +$31.8K |
|
2663
Byrna Technologies
BYRN
$97.8M
| $203K | ﹤0.01% |
+7,036
| New | +$138K |
|
|
LGF.A
2664
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $203K | ﹤0.01% |
23,718
+4,601
| +24% | +$36.3K |
|
2665
Medifast
MED
$131M
| $201K | ﹤0.01% |
11,382
-6,496
| -36% | -$121K |
|
2666
Midland States Bancorp
MSBI
$699M
| $201K | ﹤0.01% |
+8,228
| New | +$206K |
|
2667
Rayonier Advanced Materials
RYAM
$573M
| $200K | ﹤0.01% |
24,135
+3,305
| +16% | +$27.8K |
|
2668
Tiptree Inc
TIPT
$677M
| $200K | ﹤0.01% |
+9,546
| New | +$200K |
|
2669
ATN International
ATNI
$492M
| $199K | ﹤0.01% |
11,814
-2,940
| -20% | -$68.8K |
|
2670
DMC Global
BOOM
$155M
| $199K | ﹤0.01% |
26,952
+1,342
| +5% | +$12.7K |
|
2671
Century Casinos
CNTY
$35.2M
| $199K | ﹤0.01% |
61,400
| – | – |
|
|
RPC
2672
Ridgepost Capital
RPC
$987M
| $199K | ﹤0.01% |
15,757
+2,028
| +15% | +$24.7K |
|
2673
Veritone
VERI
$141M
| $199K | ﹤0.01% |
60,500
| – | – |
|
2674
Rimini Street
RMNI
$464M
| $198K | ﹤0.01% |
73,906
+4,477
| +6% | +$9.14K |
|
2675
Capricor Therapeutics
CAPR
$249M
| $197K | ﹤0.01% |
+14,242
| New | +$250K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.